Patents by Inventor Jiangjun WANG

Jiangjun WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10888615
    Abstract: Provided herein is a human monoclonal antibody 8D6 against hepatitis C virus (HCV) infection. The antibody binds to the E2 subunit of HCV capsid protein, and can prevent HCV from infecting susceptible host cells. By using the antibody variable region gene or the complementary determining region (CDR) gene, different forms of genetic engineering antibodies have been transformed and produced in any expression system of the prokaryotic and eukaryotic cells as therapeutics to prevent or treat HCV infection.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: January 12, 2021
    Assignee: SUZHOU GALAXY BIOPHARMA, CO., LTD.
    Inventors: Honglin Zhou, Jie Liu, Xin Dong, Bing Sun, Jiangjun Wang, Zhiyang Ling, Chunyan Yi, Chao Bian
  • Publication number: 20190298830
    Abstract: Provided herein is a human monoclonal antibody 8D6 against hepatitis C virus (HCV) infection. The antibody binds to the E2 subunit of HCV capsid protein, and can prevent HCV from infecting susceptible host cells. By using the antibody variable region gene or the complementary determining region (CDR) gene, different forms of genetic engineering antibodies have been transformed and produced in any expression system of the prokaryotic and eukaryotic cells as therapeutics to prevent or treat HCV infection.
    Type: Application
    Filed: April 21, 2017
    Publication date: October 3, 2019
    Applicant: Suzhou Galaxy Biopharma, Co., Ltd.
    Inventors: Honglin ZHOU, Jie LIU, Xin DONG, Bing SUN, Jiangjun WANG, Zhiyang LING, Chunyan YI, Chao BIAN
  • Patent number: D1025523
    Type: Grant
    Filed: January 3, 2022
    Date of Patent: April 30, 2024
    Assignee: SHARKNINJA (CHINA) TECHNOLOGY COMPANY LIMITED
    Inventors: Zechun Zhu, Jiangjun Zhang, Siyu Wang, Binxiang Zhao